Document is current
Any future updates will be listed below
-
Authors
Miller, Kaia C.
Geyer, Bridget
Alexopoulos, Anastasia-Stefania
Moylan, Cynthia A.
Pagidipati, Neha
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 26 October 2024
First Online: 19 November 2024
Declarations
:
: BG has no disclosures to report. KCM has no disclosures to report. ASA: Supported by the Duke Clinical and Translational Institute (CTSI) under award number KL2TR002554. CAM: Research support from GSK, Madrigal, Exact Sciences. Consultation/Advisory Panels: Boehringer Ingelheim, Novo Nordisk, GLG, Sirtex. NJP: Research support from Alnylam, Amgen, Bayer, Boehringer Ingelheim, Eggland’s Best, Eli Lilly, Novartis, Novo Nordisk, Merck. Consultation/Advisory Panels for Bayer, Boehringer Ingelheim, CRISPR Therapeutics, Eli Lilly, Esperion, AstraZeneca, Merck, Novartis, and Novo Nordisk. Executive Committee member for trials sponsored by Novo Nordisk and by Amgen. DSMB for trials sponsored by J+J and Novartis. Medical advisory board for Miga Health.
